Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04391816 · ClinicalTrials.gov registry record
COVID-19 Pandemic Impact on Alcohol (PIA) - A Natural History Study
A clinical trial of Alcohol Drinking and Alcohol-Related Disorders, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).
- Recruiting
- Registry status
- 1,500
- Enrollment target
- 1
- Study location
NCT04391816 is a study of Alcohol Drinking and Alcohol-Related Disorders that is actively recruiting participants, run by National Institute on Alcohol Abuse and Alcoholism (NIAAA). The registered enrollment target is 1,500 participants, above the 613-participant average among 85 other Alcohol Drinking trials with a reported enrollment target (145% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04391816, a study of Alcohol Drinking and Alcohol-Related Disorders, is actively recruiting participants, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).
- RECRUITING
- Registry status
- 1,500 participants
- Enrollment target
- 1
- Study location
Study Summary
Background: The SARS-CoV-2 virus has caused a pandemic infection called COVID-19. It is a global threat to people, communities, and health systems. Researchers are concerned about the mental health effects of the pandemic. They want to learn more about how it is affecting people s alcohol use and problems, and how it may continue to affect them over time. Objective: To study the impact of the COVID-19 pandemic on alcohol use and consequences in individuals across the spectrum of alcohol use and those with alcohol use disorder. Eligibility: Participants who have been screened under the NIAAA Screening, Assessment and Management Protocol (14-AA-0181) Design: Participants will complete a baseline survey by phone. It will ask about alcohol use, alcohol dependence, and stress. It covers 2 time periods: the 12 months before the pandemic started and the time since it started. Participants will get an ID code and a link to an online survey. They will complete the online survey within a week of the phone survey. Participants will complete a series of online surveys over 24 months. For the first year, surveys will be completed weekly for the first 4 weeks, then biweekly for the next 8 weeks, and then every 1-2 months for the rest of the year. For the second year, surveys will be completed every 6 months. Surveys will cover the following topics: * Alcohol use and its consequences * Other substance use * Stress * Impact of the COVID-19 pandemic * Pain * Physical health * Sleep * Quality of life. Because the course of the pandemic may change, the frequency of the surveys may change. Participation lasts 2 years.
Conditions Studied
Study Locations (1)
Maryland
- NIAAA Section on Human Psychopharmacology - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,500 participants |
| Start Date | 2020-06-03 |
| Est. Completion | 2026-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04391816
The ClinicalTrials.gov registry entry for NCT04391816 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 613-participant average among 85 other Alcohol Drinking trials with a reported enrollment target (145% higher). The listed sponsor is National Institute on Alcohol Abuse and Alcoholism (NIAAA), which has 93 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Alcohol Drinking appearing as the primary indexed condition, and to 0 interventions.
NCT04391816 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT04391816 about?
NCT04391816 is a clinical study titled "COVID-19 Pandemic Impact on Alcohol (PIA) - A Natural History Study". Background: The SARS-CoV-2 virus has caused a pandemic infection called COVID-19. It is a global threat to people, communities, and health systems. Researchers are concerned about the mental health effects of the pandemic. They want to learn more about how it is affecting people s alcohol use and p...
What is the current status of trial NCT04391816?
This trial is currently recruiting. The enrollment target is 1,500 participants. The study started on 2020-06-03. Estimated completion is 2026-12-31.
What conditions does trial NCT04391816 study?
This clinical trial studies the following conditions: Alcohol Drinking, Alcohol-Related Disorders, Psychological Stress, Pandemic.
Who is sponsoring clinical trial NCT04391816?
This trial is sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA), which has 93 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04391816 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Drinking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Alcohol and "Heat of the Moment" Sexual Decision Making
RECRUITING · NA
-
Nicotinic Receptor Genetic Variation and Alcohol Reward
RECRUITING · Phase 1
-
Acceptance and Commitment Therapy for HIV+ Hazardous Drinkers
RECRUITING · NA
-
The GLUCID Study: Effect of Alcohol Reduction and Probiotic Interventions on Cognition and Brain Glucose Metabolism in Normal Aging Adults Who Are High-Risk Alcohol Drinkers
RECRUITING · NA
-
Cannabis' Impact on Alcohol Consumption
RECRUITING · Phase 2
-
HIV and Alcohol Research Center Focused on Polypharmacy (HARP) Pilot 2 (2nd HARP Pilot Intervention)
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.